Amedisys
(NASDAQ:AMED)
$92.16
-0.30[-0.32%]
At close: Mar 28
$92.16
0[0.00%]
After Hours: 4:03PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$0.00
Lowest Price Target1
$0.00
Consensus Price Target1
$123.38

Amedisys Stock (NASDAQ:AMED), Analyst Ratings, Price Targets, Predictions

Amedisys Inc has a consensus price target of $123.38, established from looking at the 81 latest analyst ratings. The last 3 analyst ratings were released from Raymond James, RBC Capital, and Cantor Fitzgerald on March 26, 2024, March 25, 2024, and September 14, 2023. With an average price target of $67 between Raymond James, RBC Capital, and Cantor Fitzgerald, there's an implied -27.30% downside for Amedisys Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Mar
1
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Raymond James
RBC Capital
Cantor Fitzgerald
TD Cowen
Credit Suisse

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Amedisys

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/26/2024AMEDBuy Now
Amedisys
$92.16Raymond James
John Ransom
MaintainsMarket PerformGet Alert
03/25/2024AMEDBuy Now
Amedisys
$92.168.51%RBC Capital
Ben Hendrix
$97 → $100MaintainsOutperformGet Alert
09/14/2023AMEDBuy Now
Amedisys
$92.169.59%Cantor Fitzgerald
Sarah James
$100 → $101MaintainsNeutralGet Alert
07/31/2023AMEDBuy Now
Amedisys
$92.169.59%TD Cowen
Gary Taylor
$84 → $101MaintainsMarket PerformGet Alert
07/27/2023AMEDBuy Now
Amedisys
$92.169.59%Credit Suisse
Jonathan Yong
→ $101ReiteratesNeutral → NeutralGet Alert
07/06/2023AMEDBuy Now
Amedisys
$92.169.59%Jefferies
Brian Tanquilut
$98 → $101DowngradeBuy → HoldGet Alert
06/28/2023AMEDBuy Now
Amedisys
$92.16Benchmark
Bill Sutherland
DowngradeBuy → HoldGet Alert
06/27/2023AMEDBuy Now
Amedisys
$92.16Benchmark
Bill Sutherland
DowngradeBuy → HoldGet Alert
06/27/2023AMEDBuy Now
Amedisys
$92.169.59%Truist Securities
David Macdonald
$97 → $101MaintainsHoldGet Alert
06/07/2023AMEDBuy Now
Amedisys
$92.165.25%Truist Securities
David Macdonald
→ $97DowngradeBuy → HoldGet Alert
06/06/2023AMEDBuy Now
Amedisys
$92.168.51%Cantor Fitzgerald
Sarah James
$91 → $100MaintainsNeutralGet Alert
06/06/2023AMEDBuy Now
Amedisys
$92.1624.78%Benchmark
Bill Sutherland
→ $115ReiteratesBuy → BuyGet Alert
06/06/2023AMEDBuy Now
Amedisys
$92.168.51%Credit Suisse
Jonathan Yong
$115 → $100DowngradeOutperform → NeutralGet Alert
05/08/2023AMEDBuy Now
Amedisys
$92.16-8.85%TD Cowen
Gary Taylor
$95 → $84MaintainsMarket PerformGet Alert
05/05/2023AMEDBuy Now
Amedisys
$92.16-4.51%Barclays
Steve Valiquette
$93 → $88MaintainsEqual-WeightGet Alert
05/04/2023AMEDBuy Now
Amedisys
$92.165.25%Truist Securities
David Macdonald
$115 → $97MaintainsBuyGet Alert
05/04/2023AMEDBuy Now
Amedisys
$92.1611.76%Stephens & Co.
Scott Fidel
→ $103Reiterates → Equal-WeightGet Alert
04/21/2023AMEDBuy Now
Amedisys
$92.16-5.6%Cantor Fitzgerald
Sarah James
→ $87Initiates → NeutralGet Alert
04/13/2023AMEDBuy Now
Amedisys
$92.1624.78%Truist Securities
David Macdonald
$130 → $115MaintainsBuyGet Alert

FAQ

Q

What is the target price for Amedisys (AMED)?

A

The latest price target for Amedisys (NASDAQ: AMED) was reported by Raymond James on March 26, 2024. The analyst firm set a price target for $0.00 expecting AMED to fall to within 12 months (a possible -100.00% downside). 19 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Amedisys (AMED)?

A

The latest analyst rating for Amedisys (NASDAQ: AMED) was provided by Raymond James, and Amedisys maintained their market perform rating.

Q

When was the last upgrade for Amedisys (AMED)?

A

The last upgrade for Amedisys Inc happened on March 1, 2022 when UBS raised their price target to $168. UBS previously had a sell for Amedisys Inc.

Q

When was the last downgrade for Amedisys (AMED)?

A

The last downgrade for Amedisys Inc happened on July 6, 2023 when Jefferies changed their price target from $98 to $101 for Amedisys Inc.

Q

When is the next analyst rating going to be posted or updated for Amedisys (AMED)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amedisys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amedisys was filed on March 26, 2024 so you should expect the next rating to be made available sometime around March 26, 2025.

Q

Is the Analyst Rating Amedisys (AMED) correct?

A

While ratings are subjective and will change, the latest Amedisys (AMED) rating was a maintained with a price target of $0.00 to $0.00. The current price Amedisys (AMED) is trading at is $92.16, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch